Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald F Tutrone

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Urology|February 24, 2021
Reply Letter By AuthorRonald F Tutrone, William Schiff
Prostate Cancer and Prostatic Diseases|August 8, 2018
Reply to Letter to the Editor re: 'Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting'Jay White, Ronald F Tutrone
The Canadian Journal of Urology|June 17, 2020
Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injectionRonald F Tutrone, William Schiff
Prostate Cancer and Prostatic Diseases|August 29, 2019
Second Reply to Letter to the Editor re: "Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting"Jay White, Ronald F Tutrone, Mark A Reynolds
Future Oncology (London, England)|November 18, 2024
Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancerNeal D Shore, Alicia K Morgans, Ronald F Tutrone
International Urogynecology Journal and Pelvic Floor Dysfunction|January 31, 2004
Acute renal failure caused by complete bladder eversion through a vesicovaginal fistulaJames S Dunn, Alfred E Bent, Ronald F Tutrone, et al.
Clinical Genitourinary Cancer|June 2, 2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate CancerNeal D Shore, Paul F Schellhammer, Ronald F Tutrone, et al.
Therapeutic Advances in Urology|October 3, 2014
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladderMichael S Cookson, Sam S Chang, Christine Lihou, et al.
The Journal of Urology|July 12, 2005
Prostate cancer in men using testosterone supplementationFranklin D Gaylis, Daniel W Lin, Jeffrey M Ignatoff, et al.
Clinical Genitourinary Cancer|December 3, 2017
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate CancerNeal D Shore, Ronald F Tutrone, Neil F Mariados, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Urology|February 24, 2021
Reply Letter By AuthorRonald F Tutrone, William Schiff
Prostate Cancer and Prostatic Diseases|August 8, 2018
Reply to Letter to the Editor re: 'Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting'Jay White, Ronald F Tutrone
The Canadian Journal of Urology|June 17, 2020
Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injectionRonald F Tutrone, William Schiff
Prostate Cancer and Prostatic Diseases|August 29, 2019
Second Reply to Letter to the Editor re: "Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting"Jay White, Ronald F Tutrone, Mark A Reynolds
Future Oncology (London, England)|November 18, 2024
Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancerNeal D Shore, Alicia K Morgans, Ronald F Tutrone
International Urogynecology Journal and Pelvic Floor Dysfunction|January 31, 2004
Acute renal failure caused by complete bladder eversion through a vesicovaginal fistulaJames S Dunn, Alfred E Bent, Ronald F Tutrone, et al.
Clinical Genitourinary Cancer|June 2, 2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate CancerNeal D Shore, Paul F Schellhammer, Ronald F Tutrone, et al.
Therapeutic Advances in Urology|October 3, 2014
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladderMichael S Cookson, Sam S Chang, Christine Lihou, et al.
The Journal of Urology|July 12, 2005
Prostate cancer in men using testosterone supplementationFranklin D Gaylis, Daniel W Lin, Jeffrey M Ignatoff, et al.
Clinical Genitourinary Cancer|December 3, 2017
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate CancerNeal D Shore, Ronald F Tutrone, Neil F Mariados, et al.
Pageof 3